VASOPRESSIN
These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN Injection, for intravenous use Initial U.S. Approval: 2014
Approved
Approval ID
122bf9f1-3afb-4df0-986f-4c4e5fefdd3f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 9, 2023
Manufacturers
FDA
Eagle Pharmaceuticals, Inc.
DUNS: 849818161
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VASOPRESSIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code42367-570
Application NumberANDA211538
Product Classification
M
Marketing Category
C73584
G
Generic Name
VASOPRESSIN
Product Specifications
Route of AdministrationPARENTERAL
Effective DateMarch 9, 2023
FDA Product Classification
INGREDIENTS (4)
VASOPRESSINActive
Quantity: 20 U in 1 mL
Code: Y4907O6MFD
Classification: ACTIB
CHLOROBUTANOL HEMIHYDRATEInactive
Code: 3X4P6271OX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT